Patents by Inventor Bruhaspathy Miriyala

Bruhaspathy Miriyala has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDE NUCLEIC ACID MOLECULES FOR TREATMENT OF GRAM POSITIVE BACTERIAL INFECTION
    Publication number: 20200325178
    Abstract: Disclosed are compositions for the treatment of Gram-positive bacteria infection and inhibition of Gram-positive bacteria growth. The compositions comprise a peptide nucleic acid linked to a cell-penetrating peptide (PNA-CPP). The PNA-CPP conjugate and compositions inhibit expression of bacterial proteins and are optionally administered in the form of nanoparticle compositions and antimicrobial fabrics.
    Type: Application
    Filed: November 1, 2018
    Publication date: October 15, 2020
    Applicant: Techulon Inc.
    Inventors: Nrusingh Prasad MOHAPATRA, Denis K. GUENNET, Bruhaspathy MIRIYALA
  • 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    Patent number: 7560479
    Abstract: This invention relates to derivatives of 3,6-disubstituted azabicyclo hexanes. The compounds of this invention can function as muscarinic receptor antagonists and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors.
    Type: Grant
    Filed: April 10, 2003
    Date of Patent: July 14, 2009
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Anita Mehta, Bruhaspathy Miriyala, Arundutt Viswanatham Silamkoti, Jang Bahadar Gupta
  • Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    Patent number: 7517905
    Abstract: This invention relates to the derivatives of substituted azabicyclo hexanes. The compounds of this invention can function as muscarinic receptor antagonists and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of the compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
    Type: Grant
    Filed: April 9, 2003
    Date of Patent: April 14, 2009
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Anita Mehta, Bruhaspathy Miriyala, Sudershan Kumar Arora, Jang Bahadur Gupta
  • 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists
    Patent number: 7232835
    Abstract: This invention relates to derivatives of 3,6-disubstituted azabicyclo compounds. The compounds of this invention can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods for treating the diseases mediated through muscarinic receptors.
    Type: Grant
    Filed: December 10, 2002
    Date of Patent: June 19, 2007
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Anita Mehta, Arundutt Viswanatham Silamkoti, Bruhaspathy Miriyala, Sudershan Kumar Arora, Boju Srinivasulu, Bireshwar Mukherjee, Jang Bahadur Gupta
  • 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    Publication number: 20070135508
    Abstract: The present invention relates to a radio telephony network (1) supporting at least one link of a radio channel (6) for a packet data transmission service. The radio telephony network (1) comprises a plurality of network controllers (RNC). Each network controller (RNC) is connected, via an interface Iub, to at least one base radio station (B-node) supervising at least one macrocell (5a). The radio telephony network (1) additionally comprises at least one base radio microstation (B1-micronode) connected to the network controller (RNC) via an interface Iub of the same type as that connecting the base radio station (B-node) to said controller. The base radio microstation (B1 micronode) supervises at least one microcell (5b) incorporated in at least one macrocell (5a). The base radio microstation (B1-micronode) provides the packet data transmission service in the microcell (5b) on the link of the radio channel (6).
    Type: Application
    Filed: April 10, 2003
    Publication date: June 14, 2007
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Anita Mehta, Bruhaspathy Miriyala, Arundutt Silamkoti, Jang Gupta
  • Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    Publication number: 20070010568
    Abstract: This invention relates to derivatives of substituted azabicyclo hexanes. The compound of this invention can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
    Type: Application
    Filed: February 7, 2003
    Publication date: January 11, 2007
    Inventors: Anita Mehta, Bruhaspathy Miriyala, Naresh Kumar, Jang Gupta
  • Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
    Publication number: 20060281805
    Abstract: This invention relates to the derivatives of substituted azabicyclo hexanes. The compounds of this invention can function as muscarinic receptor antagonists and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to a process for the preparation of the compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods of treating the diseases mediated through muscarinic receptors.
    Type: Application
    Filed: April 9, 2003
    Publication date: December 14, 2006
    Inventors: Anita Mehta, Bruhaspathy Miriyala, Sudershan Arora, Jang Gupta
  • 3,6-Disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists
    Publication number: 20060217432
    Abstract: The invention relates to derivatives of 3,6-disubstituted azabicyclo[3.1.0]hexanes of structure (I). The compounds of this invention can function as muscarinic receptor antagonists, and can be used for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to pharmaceutical compositions containing the compounds of the present invention and the methods for treating the diseases mediated through muscarinic receptors.
    Type: Application
    Filed: December 10, 2002
    Publication date: September 28, 2006
    Inventors: Anita Mehta, Arundutt Silamkoti, Bruhaspathy Miriyala, Sudershan Arora, Boju Srinivasulu, Bireshwar Mukherjee, Jang Gupta